Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yoshihara

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
International Journal of Hematology|August 10, 2010
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donorMaiko Asakura, Kazuhiro Ikegame, Satoshi Yoshihara, et al.
European Journal of Haematology|October 5, 2012
Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantationHiroya Tamaki, Tatsuya Fujioka, Kazuhiro Ikegame, et al.
Experimental Hematology|October 9, 2007
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxisHiroyasu Ogawa, Kazuhiro Ikegame, Katsuji Kaida, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 27, 2004
Solitary right ventricle metastasis by renal cell carcinomaMitsuru Masaki, Tadashi Kuroda, Naoki Hosen, et al.
BMJ Open|October 23, 2025
Autologous peripheral blood mononuclear cell-loaded injectable cell scaffold (ICS-001) for revolutionising angiogenic therapy: a study protocol for an exploratory clinical trialKenichi Yamahara, Hirokuni Akahori, Kenichiro Kawai, et al.
Leukemia Research Reports|July 28, 2022
Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapyKyoko Yoshihara, Yoshiyuki Orihara, Tokiko Hoshiyama, et al.
Transplantation|August 19, 2004
Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantationHiroyasu Ogawa, Kazuhiro Ikegame, Manabu Kawakami, et al.
International Journal of Hematology|May 6, 2022
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantationMasahiro Teramoto, Satoshi Maruyama, Hiroya Tamaki, et al.
Bone Marrow Transplantation|June 22, 2020
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II studyKazuhiro Ikegame, Katsuji Kaida, Keiko Fukunaga, et al.
Vox Sanguinis|March 1, 2024
RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based studyTakaaki Konuma, Naoyuki Uchida, Wataru Takeda, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
International Journal of Hematology|August 10, 2010
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donorMaiko Asakura, Kazuhiro Ikegame, Satoshi Yoshihara, et al.
European Journal of Haematology|October 5, 2012
Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantationHiroya Tamaki, Tatsuya Fujioka, Kazuhiro Ikegame, et al.
Experimental Hematology|October 9, 2007
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxisHiroyasu Ogawa, Kazuhiro Ikegame, Katsuji Kaida, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 27, 2004
Solitary right ventricle metastasis by renal cell carcinomaMitsuru Masaki, Tadashi Kuroda, Naoki Hosen, et al.
BMJ Open|October 23, 2025
Autologous peripheral blood mononuclear cell-loaded injectable cell scaffold (ICS-001) for revolutionising angiogenic therapy: a study protocol for an exploratory clinical trialKenichi Yamahara, Hirokuni Akahori, Kenichiro Kawai, et al.
Leukemia Research Reports|July 28, 2022
Severe acute heart failure during or following cytokine release syndrome after CAR T-cell therapyKyoko Yoshihara, Yoshiyuki Orihara, Tokiko Hoshiyama, et al.
Transplantation|August 19, 2004
Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantationHiroyasu Ogawa, Kazuhiro Ikegame, Manabu Kawakami, et al.
International Journal of Hematology|May 6, 2022
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantationMasahiro Teramoto, Satoshi Maruyama, Hiroya Tamaki, et al.
Bone Marrow Transplantation|June 22, 2020
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II studyKazuhiro Ikegame, Katsuji Kaida, Keiko Fukunaga, et al.
Vox Sanguinis|March 1, 2024
RhD mismatch does not affect haematopoietic recovery, graft-versus-host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry-based studyTakaaki Konuma, Naoyuki Uchida, Wataru Takeda, et al.
Pageof 15